$18.53 -$0.72 (-3.7%)

04:30 PM EST on 01/21/20

Alkermes, Inc. (NASDAQ:ALKS)

CAPS Rating: 5 out of 5

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

Current Price $18.53 Mkt Cap $3.0B
Open $19.18 P/E Ratio 0.00
Prev. Close $19.24 Div. (Yield) $0.00 (0.0%)
Daily Range $18.49 - $19.30 Volume 1,795,733
52-Wk Range $18.49 - $20.63 Avg. Daily Vol. 1,494,442

Caps

How do you think NASDAQ:ALKS will perform against the market?

Add Stock to CAPS Watchlist

All Players

312 Outperform
12 Underperform
 

All-Star Players

61 Outperform
2 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NASDAQ:ALKS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

airenInDebt (68.38)
Submitted August 09, 2018

Several meds currrently in the 3rd stage of the pipeline, two on the market with one being a treatment for opiod addiction makes this a solid investment. A bonus is investing in a company whose products can actually save lives.

PickThatBooger (29.09)
Submitted November 15, 2010

Almost got the top on this one.

Recent Community Commentary

Read the most recent pitches from players about ALKS.

Recs

0
Member Avatar BlueLens (48.53) Submitted: 12/29/2019 1:54:11 PM : Outperform Start Price: $20.41 NASDAQ:ALKS Score: -10.24

Long acting injectable medication is preferred by patients for convenience. Preferred by society because adherence to treatment is better with long acting injectables. Lower side effects, like less weight gain, will improve medication adherence. Many system delivery barriers to use of injectable medications, but positive impact on public safety will win the day.

Recs

1
Member Avatar airenInDebt (68.38) Submitted: 8/9/2018 4:18:27 PM : Outperform Start Price: $44.59 NASDAQ:ALKS Score: -74.62

Several meds currrently in the 3rd stage of the pipeline, two on the market with one being a treatment for opiod addiction makes this a solid investment. A bonus is investing in a company whose products can actually save lives.

Recs

0
Member Avatar XMFRendezvous (92.29) Submitted: 4/21/2018 1:17:56 AM : Outperform Start Price: $46.31 NASDAQ:ALKS Score: -83.27

Alkermers is primarily involved in producing generic versions or "biosimilars" of already marketed name-brand drugs. The Affordable Care Act encourages the use of generic drugs, which are cheaper. R&D costs are lower, but so are the margins. This is a socially responsible business model, and is the the direction the pharmaceutical industry is headed.

Leaderboard

Find the members with the highest scoring picks in ALKS.

Score Leader

Gib323

Gib323 (< 20) Score: +622.96

The Score Leader is the player with the highest score across all their picks in ALKS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
optigon123 < 20 7/20/2009 Underperform 3M $10.57 +78.33% +251.62% +173.29 0 Comment
scottidog 59.52 9/29/2010 Underperform 5Y $14.61 +29.02% +189.89% +160.87 0 Comment
boardsecurities 29.19 8/2/2013 Underperform 5Y $33.73 -44.12% +94.59% +138.70 0 Comment
AnotherOldFart 34.48 10/12/2006 Underperform 3M $15.58 +20.99% +159.47% +138.48 0 Comment
dwn88ir 58.47 4/23/2012 Underperform 5Y $17.47 +7.90% +142.67% +134.77 0 Comment
cmc1981 29.92 3/31/2014 Underperform 5Y $43.77 -56.93% +77.15% +134.08 0 Comment
cthomas1017 98.95 8/8/2012 Underperform 5Y $17.73 +6.32% +136.50% +130.19 0 Comment
hoochkitty 32.41 8/24/2007 Underperform 5Y $16.79 +12.27% +136.56% +124.29 0 Comment
alvinbentley 29.07 6/30/2008 Underperform 5Y $12.55 +50.20% +165.96% +115.76 0 Comment
IamBetterThanYou < 20 10/20/2010 Underperform 3W $10.80 +74.54% +180.16% +105.62 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ALKS.